|
ZNF793 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.371200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.309200E-01 |
| Normal-vs-Stage2 |
5.951800E-01 |
| Normal-vs-Stage3 |
2.919200E-03 |
| Normal-vs-Stage4 |
5.553800E-02 |
| Stage1-vs-Stage2 |
5.373400E-01 |
| Stage1-vs-Stage3 |
7.101300E-03 |
| Stage1-vs-Stage4 |
1.807600E-01 |
| Stage2-vs-Stage3 |
2.350200E-01 |
| Stage2-vs-Stage4 |
5.409400E-01 |
| Stage3-vs-Stage4 |
6.571000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.928800E-01 |
| Normal-vs-AfricanAmerican |
9.307200E-01 |
| Normal-vs-Asian |
4.705800E-01 |
| Caucasian-vs-AfricanAmerican |
9.207200E-01 |
| Caucasian-vs-Asian |
6.505200E-01 |
| AfricanAmerican-vs-Asian |
6.729600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.148600E-01 |
| Normal-vs-Female |
7.851600E-01 |
| Male-vs-Female |
6.031000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.883800E-01 |
| Normal-vs-Extreme_Weight |
2.137600E-01 |
| Normal-vs-Obese |
5.697000E-01 |
| Normal-vs-Extreme_Obese |
6.389600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.517800E-01 |
| Normal_Weight-vs-Obese |
7.238000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.729200E-01 |
| Extreme_Weight-vs-Obese |
1.268600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.937600E-01 |
| Obese-vs-Extreme_Obese |
4.868600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.511200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.870000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.597600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.060400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.982200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.121200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.637830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.459200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.191900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.123900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.179800E-02 |
| Normal-VS-Type2 PRCC |
5.81410000000115E-05 |
| Normal-VS-KIRP CIMP |
6.892000E-02 |
| Normal-VS-Unclassified PRCC |
3.591600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.36046729437567E-12 |
| Type1 PRCC-VS-KIRP CIMP |
3.958400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.717880E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.580600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.140100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.199400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.962610E-01 |
| Normal-vs-N1 |
8.978300E-02 |
| Normal-vs-N2 |
2.573500E-04 |
| N0-vs-N1 |
5.930800E-01 |
| N0-vs-N2 |
7.705700E-02 |
| N1-vs-N2 |
8.944200E-02 |
|
|
